During the past decade, Studienzentrum Nord-West conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Studienzentrum Nord-West" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Alzheon Inc." with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Avraham Pharmaceuticals Ltd" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Nord-West" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Nord-West" are "Schizophrenia" (2 trials), "Alzheimer´s Disease" (1 trials), "Binge Eating Disorder" (1 trials), "Clostridium Difficile Infection" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Studienzentrum Nord-West" in a lesser frequency.

Most popular intervention types in "Studienzentrum Nord-West" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "400mg LM11A-31-BHS" (1 trials), "800mg LM11A-31-BHS" (1 trials), "BI 1358894" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Nord-West" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Nord-West". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Studienzentrum Nord-West, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Nord-West, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".